Post-earnings recap
Reported
Wed, Aug 7, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported a strong earnings per share, beating expectations by nearly 17%. However, the stock fell by 12.6% in reaction to the earnings report, indicating that investors may have been disappointed by the lack of revenue details or forward guidance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.80 | N/A | +16.96% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.